Multiple Sclerosis 'immune Exchange' Between Brain and Blood Is Uncovered Science Daily (press release) These trials used Rituximab and Ocrelizumab, both of which target a molecule called CD20 found on the surface of B cells. The new work suggests that targeting B cells could be extended into a precision strategy that would specifically tailor treatments ... |
